Vanguard Group Inc Emergent Bio Solutions Inc. Transaction History

Vanguard Group Inc

  • $5.37 Trillion
  • Q1 2025

A detailed history of Vanguard Group Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,214,003 shares of EBS stock, worth $20 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,214,003
Previous 3,200,700 0.42%
Holding current value
$20 Million
Previous $30.6 Million 48.95%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$4.66 - $11.66 $61,991 - $155,112
13,303 Added 0.42%
3,214,003 $15.6 Million
Q4 2024

Feb 11, 2025
SELL
$7.72 - $11.97 $1.52 Million - $2.36 Million
-196,926 Reduced 5.8%
3,200,700 $30.6 Million
Q3 2024

Nov 13, 2024
SELL
$5.72 - $14.77 $1.54 Million - $3.97 Million
-268,608 Reduced 7.33%
3,397,626 $28.4 Million
Q2 2024

Aug 13, 2024
BUY
$1.86 - $6.98 $473,714 - $1.78 Million
254,685 Added 7.47%
3,666,234 $25 Million
Q1 2024

May 10, 2024
BUY
$1.5 - $3.41 $655,366 - $1.49 Million
436,911 Added 14.69%
3,411,549 $8.63 Million
Q4 2023

Feb 14, 2024
BUY
$1.82 - $3.16 $597,455 - $1.04 Million
328,272 Added 12.4%
2,974,638 $7.14 Million
Q3 2023

Nov 14, 2023
SELL
$3.17 - $7.91 $5.38 Million - $13.4 Million
-1,695,976 Reduced 39.06%
2,646,366 $9 Million
Q2 2023

Aug 14, 2023
SELL
$7.35 - $13.21 $8.01 Million - $14.4 Million
-1,090,283 Reduced 20.07%
4,342,342 $31.9 Million
Q1 2023

May 15, 2023
BUY
$7.79 - $16.29 $205,274 - $429,257
26,351 Added 0.49%
5,432,625 $56.3 Million
Q4 2022

Feb 10, 2023
BUY
$11.0 - $21.45 $2.36 Million - $4.61 Million
214,788 Added 4.14%
5,406,274 $63.8 Million
Q3 2022

Nov 14, 2022
BUY
$20.09 - $35.8 $2.03 Million - $3.62 Million
101,059 Added 1.99%
5,191,486 $109 Million
Q2 2022

Aug 12, 2022
SELL
$27.42 - $43.63 $1.81 Million - $2.88 Million
-65,954 Reduced 1.28%
5,090,427 $158 Million
Q1 2022

May 13, 2022
SELL
$36.48 - $52.22 $7.5 Million - $10.7 Million
-205,650 Reduced 3.84%
5,156,381 $212 Million
Q4 2021

Feb 14, 2022
BUY
$33.11 - $55.01 $14.6 Million - $24.2 Million
440,316 Added 8.95%
5,362,031 $233 Million
Q3 2021

Nov 12, 2021
SELL
$50.07 - $66.05 $1.87 Million - $2.47 Million
-37,332 Reduced 0.75%
4,921,715 $246 Million
Q2 2021

Aug 13, 2021
BUY
$56.61 - $80.46 $281 Million - $399 Million
4,959,047 New
4,959,047 $312 Million

Others Institutions Holding EBS

# of Institutions
177
Shares Held
38.3M
Call Options Held
94.1K
Put Options Held
153K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $310M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email